The Changing Landscape for Specialty Pharmacy Patients

Marc O'Connor, chief operating officer of Curant Health, discusses potential changes patients of specialty pharmacies may experience in the near future.

Related Content:

InterviewsSpecialty Pharmacy

FDA Lifts Clinical Hold on Lenacapavir for HIV Treatment and PrEP

Expert: Cell, Gene Therapy Research Has Weathered the Storm of COVID-19, Leaving a Bright Future Ahead

Expert: Cell, Gene Therapies Provide the Important Opportunity to ‘Move Beyond Chronic Disease Management to Curative Areas’